Literature DB >> 16200036

On-site evaluation of percutaneous CT-guided fine needle aspiration of pulmonary lesions. A study of 321 cases.

Ernesto Mazza1, Cristina Maddau, Alessandro Ricciardi, Massimo Falchini, Marzia Matucci, Tommaso Ciarpallini.   

Abstract

PURPOSE: The aim of this study was to assess the usefulness of having a cytopathologist present during percutaneous CT-guided fine needle aspiration (FNA) of pulmonary lesions.
MATERIALS AND METHODS: Three hundred and twenty-one FNAs of lung lesions were performed in 312 patients (218 males, 94 females; age range: 20-86 years; mean age: 66 yrs). Nodule sizes ranged from 0.5 to 8 cm. The sampling was performed by a radiologist under CT-guidance; the calibre of the needle used was 20-25 G. Smears were prepared in the Radiology Department and stained using a quick method by a cytopathologist: the sample adequacy was assessed and, if possible, a preliminary diagnosis was made. An additional FNA was requested if the first aspirate was considered diagnostically inadequate. The diagnostic accuracy was examined by reviewing the clinical data and by correlating with the histological material and the clinical outcome.
RESULTS: Satisfactory diagnostic material was obtained in 275 of the 321 FNA (86%): 231 were malignant (72%), 8 suspicious (3%) and 36 were negative for malignancy (11%). Forty-six of the 321 specimens (14%) were considered inadequate for any diagnostic verification. An additional FNA was performed immediately in 60 cases (19%). Forty-two subjects developed pneumothorax: 21 patients (50%) of these required thoracic drainage. Blood effusion around the lesion site or adjacent to the needle path was observed in 39 patients (12%). Sensitivity was 99%, specificity was 95% and diagnostic accuracy was 99%.
CONCLUSIONS: CT guided aspiration cytology can be a safe and fast procedure for lung nodule characterisation. On-site immediate evaluation of FNA specimens can be beneficial in determining the adequacy of the aspirate and in providing accurate preliminary diagnoses of the specimens, thus allowing for rapid clinical decisions.

Entities:  

Mesh:

Year:  2005        PMID: 16200036

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  15 in total

1.  Safety and diagnostic performance of image-guided lung biopsy in the targeted therapy era.

Authors:  Marco Busso; Diego Sardo; Irene Garetto; Luisella Righi; Giulia Libero; Tiziana Vavalà; Francesco Ardissone; Silvia Novello; Mauro Papotti; Andrea Veltri
Journal:  Radiol Med       Date:  2015-05-01       Impact factor: 3.469

2.  Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin; H Gilbert Welch
Journal:  Ann Intern Med       Date:  2011-08-02       Impact factor: 25.391

3.  High diagnostic yield of endoscopic ultrasound-guided fine needle aspiration without an on-site cytopathologist.

Authors:  Shyam Sunder Sharma; Mukesh Jain; Sudhir Maharshi
Journal:  Indian J Gastroenterol       Date:  2017-03-09

4.  Does onsite cytotechnology evaluation improve the accuracy of endoscopic ultrasound-guided fine-needle aspiration biopsy?

Authors:  Fahad Alsohaibani; Safwat Girgis; Gurpal Singh Sandha
Journal:  Can J Gastroenterol       Date:  2009-01       Impact factor: 3.522

5.  Risks of Transthoracic Needle Biopsy: How High?

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Michael K Gould
Journal:  Clin Pulm Med       Date:  2013-01-01

6.  Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.

Authors:  Mario Mascalchi; Massimo Falchini; Cristina Maddau; Francesca Salvianti; Marco Nistri; Elena Bertelli; Lapo Sali; Stefania Zuccherelli; Alessandra Vella; Marzia Matucci; Luca Voltolini; Andrea Lopes Pegna; Michaela Luconi; Pamela Pinzani; Mario Pazzagli
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-26       Impact factor: 4.553

Review 7.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

8.  CT-guided fine-needle aspiration biopsy of solitary pulmonary nodules under 15 mm in diameter: time for an afterthought?

Authors:  Davide Tosi; Paolo Mendogni; Rosaria Carrinola; Alessandro Palleschi; Lorenzo Rosso; Eleonora Bonaparte; Fulvia Milena Cribiù; Stefano Ferrero; Gianluca Bonitta; Mario Nosotti
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

9.  Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.

Authors:  Mario Mascalchi; Cristina Maddau; Lapo Sali; Elena Bertelli; Francesca Salvianti; Stefania Zuccherelli; Marzia Matucci; Alessandra Borgheresi; Claudio Raspanti; Monica Lanzetta; Massimo Falchini; Ernesto Mazza; Alessandra Vella; Michaela Luconi; Pamela Pinzani; Mario Pazzagli
Journal:  J Cancer       Date:  2017-07-15       Impact factor: 4.207

10.  Basics of cytology.

Authors:  Mousa A Al-Abbadi
Journal:  Avicenna J Med       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.